Pillstats
Rx only · Injection, Powder, Lyophilized, For Solution · Intravenous

Ganciclovir Sodium

Brands: Ganciclovir · Ganciclovir Sodium

3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US4 NDCs
3 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)4678
US makers3 labelers
Packages5
DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

781552333112025 Q12025 Q22025 Q32025 Q42026 Q1
36
Rx · 2026 Q1
73
Units dispensed
-75%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it3 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Fresenius Kabi USA, LLCunknown2SUPPLYING
Slate Run Pharmaceuticals, LLCunknown2SUPPLYING
Hikma Pharmaceuticals USA Inc.unknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Dec 16, 2022
    RECALLRecall (Class II): Ganciclovir for Injection, USP, 500mg per vial, packaged in a 10-count carton, Rx Only, Mfd. by: THYMOORGAN PHARMAZIE G…

    Labeling: Label mix-up - one vial was mislabeled as Cladribine Injection 10mg/mL inside a 10-count carton of Ganciclovir 500 mg. — Recalling firm: Hikma Pharmaceuticals USA Inc. — USA Nationwide